Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
about
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common DiseaseXenobiotic perturbation of ER stress and the unfolded protein responseThe Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityChronic liver injury induced by drugs: a systematic review.Ananas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression.A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchValproic Acid and Hepatic Steatosis: A Possible Link? About a Case Report.Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicityCentral role of mitochondria in drug-induced liver injury.Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.Mechanistic review of drug-induced steatohepatitisResveratrol and vitamin E rescue valproic acid-induced teratogenicity: the mechanism of action.High-calorie diet inflates steatogenic effects of valproic acid in mice.Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.HEPATOKIN1 is a biochemistry-based model of liver metabolism for applications in medicine and pharmacology.
P2860
Q26798157-56C5EC44-6D09-4F4F-8AC9-B63CBBCB3394Q26998690-137A6B1A-865C-47A9-87CC-3D1FFE9AD94CQ28080256-72E856F0-4B83-4596-8E46-670057069734Q30278737-A9E58384-4F28-4039-A28B-77452177128AQ34093727-77391BA8-86C0-4939-B8B9-42B09CEA20D7Q34806303-B795E40A-7B7A-44F9-826A-1EE0D448D791Q36129673-8DC86B78-A38D-44C7-8994-67B067C5CECDQ37299861-9C07FFFD-5E38-4438-A6E8-4113C6C05C5BQ37656707-AD569BBE-DE0D-42D1-B46B-5E8B832909A3Q37926590-7451F8E2-9016-4E6E-8CE4-C076528E6209Q38180728-4D5C83FD-1503-4252-AD43-E18B94BAAC9CQ38581885-0B7F2A28-30F4-41EA-930A-C628CC41340CQ46940049-9452145E-E19D-4D74-BCD3-00B274F25AB6Q53218331-A36534ED-7122-49B1-95C9-E5BFAB3EC5E1Q54704593-20DA0DDE-B5F0-41F6-AAC2-8416C0285144Q54856174-585B3F0D-EA8C-4B92-AF8D-CEBBF1DA2B5CQ55283905-085683CB-2111-41AB-9159-605FE1B2C945
P2860
Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Inhibition of hepatic carnitin ...... f valproate-induced steatosis.
@en
Inhibition of hepatic carnitine palmitoyl-transferase I
@nl
type
label
Inhibition of hepatic carnitin ...... f valproate-induced steatosis.
@en
Inhibition of hepatic carnitine palmitoyl-transferase I
@nl
prefLabel
Inhibition of hepatic carnitin ...... f valproate-induced steatosis.
@en
Inhibition of hepatic carnitine palmitoyl-transferase I
@nl
P2093
P1476
Inhibition of hepatic carnitin ...... f valproate-induced steatosis.
@en
P2093
Carina Prip-Buus
Cátia C P Aires
Femke Stet
Lodewijk Ijlst
Margarida F B Silva
Marinus Duran
P304
P356
10.1016/J.BCP.2009.10.011
P407
P577
2009-10-23T00:00:00Z